The pre-diagnostic phase of Parkinson s
|
|
- Lawrence Taylor
- 7 years ago
- Views:
Transcription
1 The pre-diagnostic phase of Parkinson s Disease Anthony Schapira London, UK GPSRC CNS RTG 1
2 Early diagnosis is it possible? Clinical i l evaluation Imaging Gene testing Biochemistry GPSRC CNS RTG 2
3 Early diagnosis does it matter? Diagnosis i for diagnosis i sake Testing neuroprotective drugs Prescribing neuroprotective drugs GPSRC CNS RTG 3
4 Pre-symptomatic period of PD? Clinical i l clues range from 3 8 years Pathological clues suggest 7 8 years Imaging g clues suggest 7 8 years Genetic causes can be decades GPSRC CNS RTG 4
5 Symptoms of PD Motor symptoms Rest tremor Rigidity Bradykinesia Non-motor symptoms Sensory phenomena Loss of smell REM behaviour disorder (RBD) Depression Dementia Autonomic dysfunction GPSRC CNS RTG 5
6 Diagnostic markers for PD Unilateral l onset (asymmetry) Bradykinesia Rigidity Resting tremor Good and sustained response to dopaminergic therapy GPSRC CNS RTG 6
7 Non-motor symptoms at presentation of PD 21% had only NMS at first visit it median to PD diagnosis i is 1.6 years vs 1.0 years Pain in 53% Urinary problems 16.5% Depression or anxiety 12% Non-specific cognitive impairment 5.5% No difference in time to hallucinations (10 years), dyskinesias (8 years), duration of PD to death (14 years) or age at death (75 years) O Sullivan et al. Mov Disord 2008;23: GPSRC CNS RTG 7
8 Diagnosis of PD Primary care and general physicans accuracy is about 60% Neurologist s s accuracy about 85% Movement disorder specialists: 99% (accuracy in first 4 years 75%) Hughes et al. Brain 2002;125: GPSRC CNS RTG 8
9 Pre-symptomatic markers of PD Olfactory loss Depression REM sleep disorder Constipation GPSRC CNS RTG 9
10 Hyposmia in PD 361 asymptomatic ti relatives of PD patients t 11% hyposmic (40 relatives) 18% of hyposmics (7 patients) had abnormal SPECT 5 patients had worse single photon emission computed tomography (SPECT) at 2 years 10% (n=4) of hyposmic 1 st degree relatives developed PD within 2 years ( 1% all relatives) Ponsen et al. Ann Neurol 2004;56: GPSRC CNS RTG 10
11 Conclusions Hyposmia in asymptomatic ti relatives of patients t with PD is associated with a 10% risk of developing PD Increased rate of binding decline in another 5 patients may increase the risk to as high as 22% Honolulu study: hyposmia <25% Odds ratio 5.2 (10/549); 25 50% Odds ratio 3.1 within 4 years Intact olfactory function lowers the risk of developing e PD (no higher than general population) Webster Ross et al. Ann Neurol 2007;63; GPSRC CNS RTG 11
12 Depression in PD Depression or panic attacks may precede the onset of motor symptoms in up to 44% Mean period of depression preceding PD was 5 years. Patients were younger, less impaired and had positive family history Santamaria et al. J Neurology 1986;36: GPSRC CNS RTG 12
13 Constipation as a risk factor for PD 24 years prospective follow-up data from 6790 men aged years 96 incident cases of PD Relative risk (RR) for PD (adjusted for age and risk factors) significantly increased in males with < 1 bowel movement per day vs 1 bowel movement per day: RR = 2.7 vs 2 bowel movements per day: RR = 4.1 vs > 2 bowel movements per day: RR = 4.5 Abbott et al. Neurology 2001;57: GPSRC CNS RTG 13
14 RBD and Parkinsonism Approx. 30% of PD may develop RBD Idiopathic RBD strongly associated with neurodegeneration: 19 38% at 5 years and 40 60% at 10 years approx. 50% PD PD patients with RBD: akinetic rigid type, more autonomic problems and cognitive impairment Gagnon et al. Lancet Neurol 2006;5:424 32; Iranzo et al. Lancet Neurol 2006;5:572 7; Schenck et al. Neurology 1996;46:388 93; Postuma et al. Neurology 2006;66: GPSRC CNS RTG 14
15 A UP PDRS Score UPDRS Part III B umber Alternate Tap Test N of Taps Alternate Tap Test RBD Control o RBD Control o C 20 Purdue PegBoard D 14 Timed Up and Go umber of Pegs N Time (S Seconds) RBD Control RBD Control Adapted from Postuma et al. Neurology 2006;66: GPSRC CNS RTG 15
16 Olfactory discrimination The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 16
17 Vision (colour) The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 17
18 Colour hue and other factors The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 18
19 Motor speed correlates with hyposmia The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 19
20 New interpretation of Braak hypothesis: PD is a prion disease The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 20
21 Favourable factors The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 21
22 Early diagnosis is it possible? Clinical i l evaluation Imaging Gene testing Biochemistry GPSRC CNS RTG 22
23 Early diagnosis is it possible? Clinical i l evaluation Imaging Gene testing Biochemistry GPSRC CNS RTG 23
24 Inherited Parkinsonism The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 24
25 LRRK2 mutation worldwide prevalence The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 25
26 Healy line graph The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 26
27 Healey Kaplan Meier Healy et al. Lancet Neurol 2008;7: GPSRC CNS RTG 27
28 Gluecocerbrosidase mutations The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 28
29 Early diagnosis is it possible? Clinical i l evaluation Imaging Gene testing Biochemistry (urate) GPSRC CNS RTG 29
30 Common pathways underlying PD pathogenesis The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 30
31 Early diagnosis is it possible? Clinical evaluation Imaging Gene testing Biochemistry GPSRC CNS RTG 31
32 Incidence rate line graph The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 32
33 Kempster graph The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 33
34 Conclusions Even with current criteria, diagnosis of PD is only 75% accurate at presentation Certain non-motor features precede motor deficits, but none are specific for PD Combinations help enrich a population, but numbers converting to PD are small Genetic factors are uncommon and penetrance variable Heterogenicity of PD aetiology will confound early markers Ultimately, PD risk will likely be estimated by a complex of genetic and phenotypic (clinical and biochemical) markers and imaging GPSRC CNS RTG 34
35 Copyright statements Slide 16 Slide , reproduced with permission from Wolters Kluwer Health 2008, reproduced with permission from Elsevier 35
What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician
What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician Overview of presentation Case history Video example pre and post treatment Historical review PD in the UK Epidemiology and aetiology Making
More informationUnmet Needs for Parkinson s Disease Therapeutics
Unmet Needs for Parkinson s Disease Therapeutics Coalition Against Major Diseases & FDA Workshop October 20, 2014 Caroline M Tanner MD, PhD Director, Parkinson's Disease Research Education and Clinical
More informationMr James Garrard University of Leicester May 2014
Parkinson s disease exemplifies the art and science of geriatric medicine. Introduction First described by Dr. James Parkinson in the classic essay The Shaking Palsy in 1817 (1), Parkinson s disease is
More informationDementia & Movement Disorders
Dementia & Movement Disorders A/Prof Michael Davis Geriatrician ACT Health & GSAHS ANU Medical School Eastern Dementia Network Aged and Dementia Care Symposium Bateman s Bay, 22 October 2010 Types of Dementia
More informationLewy body dementia Referral for a Diagnosis
THE Lewy Body society The more people who know, the fewer people who suffer Lewy body dementia Referral for a Diagnosis Lewy Body Dementias REFERRAL FOR A DIAGNOSIS In the UK people with all forms of dementia
More informationParkinson's s disease - a
Parkinson's Disease Parkinson's s disease - a progressive disorder of the nervous system that affects movement. The most common perception of Parkinson s is the patient having tremors. Hands shaking, inability
More informationParkinson s Disease - A Junior Doctor s Survival Guide
Parkinson s Disease - A Junior Doctor s Survival Guide Professor Richard Walker Consultant Geriatrician Hon. Professor of Ageing & Interna
More informationPARKINSON S DISEASE AND PARKINSONISM. Dr Phil Wood Geriatrician, Waitemata DHB Clinical Unit Leader, Waikato DHB
PARKINSON S DISEASE AND PARKINSONISM Dr Phil Wood Geriatrician, Waitemata DHB Clinical Unit Leader, Waikato DHB OUTLINE Covering:- Why this is an important area of Medical and Psychiatric care The variety
More informationEmergency Room Treatment of Psychosis
OVERVIEW The term Lewy body dementias (LBD) represents two clinical entities dementia with Lewy bodies (DLB) and Parkinson s disease dementia (PDD). While the temporal sequence of symptoms is different
More informationPARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS
PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS De Anna Looper, RN CHPN Corporate Clinical Consultant / Legal Nurse Consultant Carrefour Associates L.L.C. PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS
More informationParkinson s prevalence in the United Kingdom (2009)
Parkinson s prevalence in the United Kingdom (2009) Contents Summary 3 Background 5 Methods 6 Study population 6 Data analysis 7 Results 7 Parkinson's prevalence 7 Parkinson's prevalence among males and
More informationSLEEP AND PARKINSON S DISEASE
A Practical Guide on SLEEP AND PARKINSON S DISEASE MICHAELJFOX.ORG Introduction Many people with Parkinson s disease (PD) have trouble falling asleep or staying asleep at night. Some sleep problems are
More informationParkinson s Disease: Factsheet
Parkinson s Disease: Factsheet Tower Hamlets Joint Strategic Needs Assessment 2010-2011 Executive Summary Parkinson s disease (PD) is a progressive neuro-degenerative condition that affects a person s
More informationCurrent evidence suggests that Parkinson s tends to develop
About Parkinson's Diagnosing Parkinson s Current evidence suggests that Parkinson s tends to develop gradually and it may be many months, even years, before the symptoms become obvious enough for you to
More informationParkinson's disease. Definition. Symptoms
Parkinson's disease Definition Parkinson's disease is a progressive disorder of the nervous system that affects your movement. It develops gradually, sometimes starting with a barely noticeable tremor
More informationClinical Research in Parkinson s Disease: The Advances, Challenges, and Importance of Rater Training
Clinical Research in Parkinson s Disease: The Advances, Challenges, and Importance of Rater Training Marian A. Ormont, MD epharmasolutions, A WIRB-Copernicus Group Company April is Parkinson s disease
More informationParkinson s Disease Symptoms Guide
Parkinson s Disease Symptoms Guide Some symptoms of Parkinson s disease (PD) are hard for even specialists to detect. Others are obvious even to an untrained eye. Parkinson s symptoms are different for
More informationTraumatic brain injury (TBI)
Traumatic brain injury (TBI) A topic in the Alzheimer s Association series on understanding dementia. About dementia Dementia is a condition in which a person has significant difficulty with daily functioning
More informationHow To Treat An Elderly Patient
1. Introduction/ Getting to know our Seniors a. Identify common concepts and key terms used when discussing geriatrics b. Distinguish between different venues of senior residence c. Advocate the necessity
More informationDiagnosing Parkinson s disease (PD) in
MedicineToday 2015; 16(1): 12-18 PEER REVIEWED FEATURE 2 CPD POINTS The clinical challenge of early Parkinson s disease SIMON J.G. LEWIS MB BCh, BSc, MRCP, FRACP, MD Early Parkinson s disease may be challenging
More informationSleep Difficulties. Insomnia. By Thomas Freedom, MD and Johan Samanta, MD
Sleep Difficulties By Thomas Freedom, MD and Johan Samanta, MD For most people, night is a time of rest and renewal; however, for many people with Parkinson s disease nighttime is a struggle to get the
More informationUnderstanding Parkinson s Disease
Understanding Parkinson s Disease Irene Oh, MD Neurologist, Movement Disorders Specialist The Neurology Center of Southern California, Encinitas & Escondido Introduction PD was first described in 1817
More informationABC s of Parkinson s Disease 4/29/15 Karen Parenti, MS, PsyD
ABC s of Parkinson s Disease 4/29/15 Karen Parenti, MS, PsyD What is Parkinson s Disease? Parkinson's disease is a progressive disorder of the nervous system that affects movement. It develops gradually,
More informationParkinson s Disease: A Review of Motor and Nonmotor Symptoms
Diana Hong Parkinson s Disease: A Review of Motor and Nonmotor Symptoms Abstract: Although Parkinson s disease (PD) is considered a motor system disorder caused by the degeneration of dopaminergic neurons
More informationHD 101 for newcomers. Martha A. Nance MD Hennepin County Medical Center HD COE Struthers Parkinson s Center
HD 101 for newcomers Martha A. Nance MD Hennepin County Medical Center HD COE Struthers Parkinson s Center The information provided by speakers in workshops, forums, sharing/networking sessions and any
More informationVersion 1.1 1 18/04/11
Department of Neurology Southern General Hospital 1345 Govan Road Glasgow G51 4TF PRoBaND: Parkinson's Repository of Biosamples and Networked Datasets Information Sheet for: Relatives of patients with
More informationParkinson s Disease (PD)
Parkinson s Disease (PD) Parkinson s disease (PD) is a movement disorder that worsens over time. About 1 in 100 people older than 60 has Parkinson s. The exact cause of PD is still not known, but research
More informationPrimary Endpoints in Alzheimer s Dementia
Primary Endpoints in Alzheimer s Dementia Dr. Karl Broich Federal Institute for Drugs and Medical Devices (BfArM) Kurt-Georg-Kiesinger-Allee 38, D-53175 Bonn Germany Critique on Regulatory Decisions in
More informationMeeting the Needs of Aging Persons. Aging in Individuals with a
Meeting the Needs of Aging Persons with Developmental Disabilities Cross Network Collaboration for Florida Aging in Individuals with a Developmental Disability Module 3 Based on ADRC training developed
More informationSinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022
Brochure More information from http://www.researchandmarkets.com/reports/2834728/ Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022 Description: Sinemet (Parkinson s Disease) - Forecast
More information1: Motor neurone disease (MND)
1: Motor neurone disease (MND) This section provides basic facts about motor neurone disease (MND) and its diagnosis. The following information is an extracted section from our full guide Living with motor
More informationTinnitus: a brief overview
: a brief overview sufferers experience sound in the absence of an external source. Sounds heard in tinnitus tend to be buzzing, hissing or ringing rather than fully-formed sounds such as speech or music.
More informationSteps to getting a diagnosis: Finding out if it s Alzheimer s Disease.
Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Memory loss and changes in mood and behavior are some signs that you or a family member may have Alzheimer s disease. If you have
More informationPARTNERS IN PARKINSON S. Parkinson s Disease Guide
PARTNERS IN PARKINSON S Parkinson s Disease Guide Each individual travels his or her own journey with Parkinson s disease, often encountering new challenges as symptoms progress and care needs change.
More informationPARKINSON S DISEASE INTRODUCTION. Parkinson s disease is defined as a disease of the nervous system that affects voluntary movement.
PARKINSON S DISEASE INTRODUCTION Parkinson s disease is a disorder of the brain and the nervous system. It is one of the more common neurological diseases in people over the age of 60, and it is more common
More informationCalendar of events NEUROLOGY
Calendar of events 2016 NEUROLOGY Rome, Italy 29 January 2016 Updates on MS treatment management Project an individualized treatment plan in MS Explain how to manage patients day to day issues List the
More informationTrauma Insurance Claims Seminar Invitation
Trauma Insurance Claims Seminar Invitation Introduction Since the development of Trauma Insurance in Australia in the 1980s, the product has evolved at a great pace. Some of the challenges faced by claims
More informationMultiple Sclerosis: New Perspectives on the Patient Journey
Multiple Sclerosis: New Perspectives on the Patient Journey Prepared by Milliman, Inc., NY Bruce Pyenson, FSA, MAAA Principal and Consulting Actuary Melissa Fredericks, FSA, MAAA Principal and Consulting
More informationMCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease
MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease Outline of Today s Lecture Why is Alzheimer s disease a problem? What is Alzheimer s Disease? What causes Alzheimer s disease? How can
More informationMental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca
Mental health issues in the elderly January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca Cognitive Disorders Outline Dementia (294.xx) Dementia of the Alzheimer's Type (early and late
More information06/06/2012. The Impact of Multiple Sclerosis in the Pacific Northwest. James Bowen, MD. Swedish Neuroscience Institute
The Impact of Multiple Sclerosis in the Pacific Northwest James Bowen, MD Multiple Sclerosis Center Multiple Sclerosis Center Swedish Neuroscience Institute 1 2 Motor Symptoms of MS Weakness Spasticity
More informationJournal Club. Parkinsonismo iatrogeno
PROGETTO UNIVA 2013 Journal Club Parkinsonismo iatrogeno Pietro Gareri, MD, PhD Geriatra ASP Catanzaro Lamezia Terme 3 Luglio 2013 Drug-induced parkinsonism (DIP) was recognized in the early 1950s as a
More informationRörelserubbningar och Parkinson, hur svårt kan det vara. En översikt och problematisering av en folksjukdom Örjan Skogar, MD,PhD
Rörelserubbningar och Parkinson, hur svårt kan det vara En översikt och problematisering av en folksjukdom Örjan Skogar, MD,PhD Man räknar med att 11-19 personer /100 000 invånare insjuknar i Parkinson
More informationDementia with Lewy bodies
IS 18 April 2011 Information sheet Dementia with Lewy bodies Introduction... 1 Key points... 1 What is dementia with Lewy bodies?... 1 How many people are affected by DLB?.. 2 What is the cause?... 2 Symptoms...
More informationRecognition and Treatment of Depression in Parkinson s Disease
Recognition and Treatment of Depression in Parkinson s Disease Web Ross VA Pacific Islands Health Care System What is depression? Depression is a serious medical condition that affects a person s feelings,
More informationClinically isolated syndrome (CIS)
Clinically isolated syndrome (CIS) Spirella Building, Letchworth, SG6 4ET 01462 476700 www.mstrust.org.uk reg charity no. 1088353 We hope you find the information in this factsheet helpful. If you would
More informationPatients with dementia and other types of structural brain injury are predisposed to delirium (i.e., abrupt onset, temporary confusion caused by
Dementia is the permanent loss of multiple intellectual functions resulting from neuronal death. Dementia afflicts 10% of individuals over the age of 65 and these patients survive approximately seven years
More informationMOTION AND E-MOTION. Andrea Cavanna MD PhD FRCP
MOTION AND E-MOTION Andrea Cavanna MD PhD FRCP Consultant in Behavioural Neurology, BSMHFT, Birmingham, UK Hon Professor in Neuropsychiatry, Aston University, Birmingham, UK Hon Reader in Neuropsychiatry,
More informationDISABILITY CLAIMS UNDER INSURANCE POLICIES
DISABILITY CLAIMS UNDER INSURANCE POLICIES This article by our legal contributor and Information & Referral Associate is to assist persons living with Parkinson s in making claims for disability benefits
More informationMultiple System Atrophy guide (http://www.msaweb.co.uk/msaguide.htm)
Multiple System Atrophy guide (http://www.msaweb.co.uk/msaguide.htm) Accessing information on Multiple System Atrophy (MSA) can be hard work. The Sarah Matheson Trust (SMT) produces a guide to MSA that
More informationPARKINSON SOCIETY CANADA NATIONAL RESEARCH PROGRAM. National Research Program 1
PARKINSON SOCIETY CANADA NATIONAL RESEARCH PROGRAM National Research Program 1 Leading the way in Parkinson s research Research holds the key to unlock the mysteries of Parkinson s disease. Scientific
More informationDepression and Anxiety in Parkinson s disease
Depression and Anxiety in Parkinson s disease Greg Pontone, MD Director, Movement Disorders Psychiatry Clinical Programs at Johns Hopkins Morris K. Udall Parkinson's Disease Research Center Johns Hopkins
More information6/3/2011. High Prevalence and Incidence. Low back pain is 5 th most common reason for all physician office visits in the U.S.
High Prevalence and Incidence Prevalence 85% of Americans will experience low back pain at some time in their life. Incidence 5% annual Timothy C. Shen, M.D. Physical Medicine and Rehabilitation Sub-specialty
More informationGraphical tasks to aid in diagnosing and monitoring Parkinson s disease
Graphical tasks to aid in diagnosing and monitoring Parkinson s disease Esther J. Smits The studies described in this thesis were part of the DiPAR project for which funding was received from the EC in
More informationWelcome to the Medical Risk Webinar: a taster of Assessing and Managing Medical Risk for Insurers courses. 26 April 2013
Welcome to the Medical Risk Webinar: a taster of Assessing and Managing Medical Risk for Insurers courses 26 April 2013 1 Parkinson s Disease & Multiple Sclerosis Dr Nick Niven Jenkins 2 Movement Human
More informationDisease Surveillance in New Jersey Spring 2006
Creutzfeldt-Jakob Disease Surveillance in New Jersey Spring 2006 Shereen Brynildsen, MS Epidemiologist, Infectious & Zoonotic Disease Program New Jersey Department of Health & Senior Services Phone: 609-588
More informationFit, (falls) and funny turns. Richard J Davenport Consultant Neurologist Edinburgh
Fit, (falls) and funny turns Richard J Davenport Consultant Neurologist Edinburgh The plan Epilepsy nuggets 10 things I would like GPs to know This week s FS clinic What is epilepsy? Characterised by two
More information1/25/2015. Idiopathic restless legs syndrome: clinical definition, pathophysiology and treatment. Five essential criteria (all must be met)
Idiopathic restless legs syndrome: clinical definition, pathophysiology and treatment Joan Santamaria, MD Neurology service, Multidisciplinary Sleep Disorders Unit Hospital Clínic de Barcelona University
More informationFUNCTIONAL EEG ANALYZE IN AUTISM. Dr. Plamen Dimitrov
FUNCTIONAL EEG ANALYZE IN AUTISM Dr. Plamen Dimitrov Preamble Autism or Autistic Spectrum Disorders (ASD) is a mental developmental disorder, manifested in the early childhood and is characterized by qualitative
More informationAlzheimer s disease. What is Alzheimer s disease?
Alzheimer s disease What is Alzheimer s disease? What we know about dementia and Alzheimer s disease Alzheimer s disease is the most common of a large group of disorders known as dementias. It is an irreversible
More informationREHABILITATION MEDICINE by PROFESSOR ANTHONY WARD
REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD What is Rehabilitation Medicine? Rehabilitation Medicine (RM) is the medical specialty with rehabilitation as its primary strategy. It provides services
More informationProstate Cancer Patients Report on Benefits of Proton Therapy
Prostate Cancer Patients Report on Benefits of Proton Therapy Dobson DaVanzo & Associates, LLC Vienna, VA 703.260.1760 www.dobsondavanzo.com Prostate Cancer Patients Report on Benefits of Proton Therapy
More informationAn Introduction to Lewy Body Dementia
An Introduction to Lewy Body Dementia A special publication for people newly diagnosed with Lewy body dementia and those still seeking answers. You don t have to face LBD alone. Increasing Knowledge Sharing
More informationPrevalence of Parkinsonism and its aetiological subtypes within patients with movement disorders
Research papers Prevalence of and its aetiological subtypes within patients with movement disorders D G S V D Gajasinghe* AL 2002 batch of students, Faculty of Medicine, University of Colombo Abstract
More informationAlcohol Disorders in Older Adults: Common but Unrecognised. Amanda Quealy Chief Executive Officer The Hobart Clinic Association
Alcohol Disorders in Older Adults: Common but Unrecognised Amanda Quealy Chief Executive Officer The Hobart Clinic Association The Hobart Clinic Association Not-for-profit private Mental Health Service
More informationPrimary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment
Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Kinga Szigeti, MD Associate Professor UBMD Neurology UB Department of Neurology Questions How do we differentiate
More informationadaptations whenever possible, to prevent or reduce the occurrence of challenging behaviours.
POSITION STATEMENT on Management of Challenging Behaviours in People with Dementia 1. AIM OF THE POSITION STATEMENT This position statement applies to people living in supported accommodation and those
More informationInternational Journal of Economics, Commerce and Management United Kingdom Vol. II, Issue 2, 2014
International Journal of Economics, Commerce and Management United Kingdom Vol. II, Issue 2, 2014 http://ijecm.co.uk/ ISSN 2348 0386 HEALTHCARE MANAGEMENT AND PSYCHOLOGICAL WELL-BEING IN PATIENTS WITH
More informationChemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015
Chemobrain Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015 Terminology Chemotherapy-associated cognitive dysfunction Post-chemotherapy cognitive impairment Cancer treatment-associated cognitive
More informationFatigue in MS: 2005 update B. Colombo University of Milan - HSR
Fatigue in MS: 2005 update B. Colombo University of Milan - HSR Fatigue in MS One of the more disabling symptoms Affects about 75/90 % of the patients May be the onset symptom Transient or chronic May
More informationCancer research in the Midland Region the prostate and bowel cancer projects
Cancer research in the Midland Region the prostate and bowel cancer projects Ross Lawrenson Waikato Clinical School University of Auckland MoH/HRC Cancer Research agenda Lung cancer Palliative care Prostate
More informationBiomarkers for Alzheimer's Disease in Down Syndrome
Biomarkers for Alzheimer's Disease in Down Syndrome Brad Christian, Ph.D. Waisman Laboratory for Brain Imaging Outline Rationale for Studying AD in Down Syndrome Background of Alzheimer s Disease Biomarkers
More informationA Definition of Multiple Sclerosis
English 182 READING PRACTICE by Alyx Meltzer, Spring 2009 Vocabulary Preview (see bolded, underlined words) gait: (n) a particular way of walking transient: (adj) temporary; synonym = transitory remission:
More informationCBT IN THE CITY. adjusted to the news of being with MS? April 2013. Experts at your fingertips call now. Check out our new services in you local area
April 2013 Experts at your fingertips call now CBT IN THE CITY Check out our new services in you local area contents. A message from Susie, Information Multiple Sclerosis CBT can make a difference on the
More informationNEUROLOGICAL REVIEW SECTION EDITOR: DAVID E. PLEASURE, MD. Predicting Motor Decline and Disability in Parkinson Disease
SECTION EDITOR: DAVID E. PLEASURE, MD Predicting Motor Decline and Disability in Parkinson Disease A Systematic Review NEUROLOGICAL REVIEW Connie Marras, MD; Paula Rochon, MD, MPH; Anthony E. Lang, MD
More informationJ/601/2874. This unit must be assessed in accordance with Skills for Care and Development s QCF Assessment Principles.
Unit 13: Dementia Awareness Unit code: DEM 201 Unit reference number: J/601/2874 QCF level: 2 Credit value: 2 Guided learning hours: 17 Unit summary The aim of the unit is to enable learners to gain knowledge
More informationManagement of Parkinson s Disease in Primary Care
Management of Parkinson s Disease in Primary Care Dr June Tan National University Hospital System (NUHS) Division of Neurology Senior Consultant Topics: Diagnosing PD Choice of medication in the de novo
More informationMultiple Sclerosis Society of Canada. CADA Presentation May 4, 2011
Multiple Sclerosis Society of Canada CADA Presentation May 4, 2011 1 MS Society s Mission To be a leader in finding a cure for multiple sclerosis and enabling people affected by MS to enhance their quality
More informationAsymptomatic HIV-associated Neurocognitive Disorder (ANI) Increases Risk for Future Symptomatic Decline: A CHARTER Longitudinal Study
Asymptomatic HIV-associated Neurocognitive Disorder (ANI) Increases Risk for Future Symptomatic Decline: A CHARTER Longitudinal Study Robert Heaton, PhD 1, Donald Franklin, BS 1, Steven Woods, PsyD 1,
More informationHow To Write Long Term Care Insurance
By Lori Boyce, AVP Risk Management and R&D Underwriting long term care insurance: a primer Every day Canadians die, are diagnosed with cancer, have heart attacks and become disabled and our insurance solutions
More informationTeen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents
Teen Misuse and Abuse of Alcohol and Prescription Drugs Information for Parents Terminology Misuse: Using a drug in a way in which it was not intended Example: Using a higher dose of medication than was
More informationAlzheimer's: The Latest Assessment and Treatment Strategies
Questions from chapter 1 Alzheimer's: The Latest Assessment and Treatment Strategies 1) What is a loss of cognitive and intellectual powers without changes in consciousness. a) dementia b) delusions c)
More informationDepression in Older Persons
Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression
More informationDepression and its Treatment in Older Adults. Gregory A. Hinrichsen, Ph.D. Geropsychologist New York City
Depression and its Treatment in Older Adults Gregory A. Hinrichsen, Ph.D. Geropsychologist New York City What is Depression? Everyday use of the word Clinically significant depressive symptoms : more severe,
More informationCLINICAL PRACTICE GUIDELINES FOR PHYSICAL THERAPY IN PATIENTS WITH PARKINSON'S DISEASE
CLINICAL PRACTICE GUIDELINES FOR PHYSICAL THERAPY IN PATIENTS WITH PARKINSON'S DISEASE Charbel MACARI Physical Therapist, AUBMC Master in Neurological Rehabilitation OUTLINE Definition, Epidemiology and
More informationOutcome of in-patient Treatment for Severe Motor Conversion Disorder - does it work? A.S.David, R.McCormack and Lishman Unit MDT
Outcome of in-patient Treatment for Severe Motor Conversion Disorder - does it work? A.S.David, R.McCormack and Lishman Unit MDT Evidence to date: inpatient rehab Inpatient multi-disciplinary intervention
More informationGuide to Assessment Scales in Parkinson s Disease
Guide to Assessment Scales in Parkinson s Disease Pablo Martinez-Martin Research Unit, Alzheimer Centre Reina Sofia Foundation and Centre for Networked Biomedical Research on Neurodegenerative Diseases
More informationTourette syndrome and co-morbidity
Tourette syndrome and co-morbidity Nanette M.M. Mol Debes, M.D., Ph.D. Tourette clinic, Herlev University Hospital, Denmark Outline of presentation Research project Herlev University Hospital Denmark Prevalence
More informationNEURON AND NEURAL TRAMSMISSION: ANATOMY OF A NEURON. created by Dr. Joanne Hsu
NEURON AND NEURAL TRAMSMISSION: ANATOMY OF A NEURON NEURON AND NEURAL TRAMSMISSION: MICROSCOPIC VIEW OF NEURONS A photograph taken through a light microscope (500x) of neurons in the spinal cord. NEURON
More informationDiagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) (APA, 2001) 10
5. Diagnosis Questions to be answered: 5.1. What are the diagnostic criteria for ADHD in children and adolescents? 5.2. How is ADHD diagnosed in children and adolescents? Who must diagnose it? 5.3. Which
More informationResearch 2004-2006. Theresa A. Zesiewicz, MD FAAN Parkinson s Disease and Movement Disorders Center USF
Research 2004-2006 Theresa A. Zesiewicz, MD FAAN Parkinson s Disease and Movement Disorders Center USF 1. Essential Tremor Most common adult movement disorder in the world 1. Zesiewicz TA, Elble R, Louis
More informationThe Burden of Pain Among Adults in the United States
P F I Z E R F A C T S The Burden of Pain Among Adults in the United States Findings from the National Health and Nutrition Examination Survey, the National Health Care Surveys, and the National Health
More informationCerebral palsy can be classified according to the type of abnormal muscle tone or movement, and the distribution of these motor impairments.
The Face of Cerebral Palsy Segment I Discovering Patterns What is Cerebral Palsy? Cerebral palsy (CP) is an umbrella term for a group of non-progressive but often changing motor impairment syndromes, which
More information09/05/2014. Painting pictures of the brain with numbers. Overview
Painting pictures of the brain with numbers Neurology for Insurers Dr Ian Cox & Adele Groyer (Gen Re) Overview Critical Illness Product Background Why should we be interested in neurology? Consult our
More informationIntellectual Symptoms Amnesia: Loss of memory function
Definition of Dementia (de mens) Latin for out of mind Permanent loss of multiple intellectual functions Alois Alzheimer first described this disease in 1906 in a brain specimen from an autopsy. Alzheimer
More informationsymptoms of Incontinence
Types, causes and symptoms of Urinary Incontinence Aims and Objectives Aim: To have an understanding of the types and causes of urinary incontinence. Objectives: To be aware of the incidence and prevalence
More informationFastTest. You ve read the book... ... now test yourself
FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to
More informationCerebral palsy, neonatal death and stillbirth rates Victoria, 1973-1999
Cerebral Palsy: Aetiology, Associated Problems and Management Lecture for FRACP candidates July 2010 Definitions and prevalence Risk factors and aetiology Associated problems Management options Cerebral
More informationADHD AND ANXIETY AND DEPRESSION AN OVERVIEW
ADHD AND ANXIETY AND DEPRESSION AN OVERVIEW A/Professor Alasdair Vance Head, Academic Child Psychiatry Department of Paediatrics University of Melbourne Telephone: 9345 4666 Facsimile: 9345 6002 Email:
More informationSocial Security Disability Insurance and young onset dementia: A guide for employers and employees
Social Security Disability Insurance and young onset dementia: A guide for employers and employees What is Social Security Disability Insurance? Social Security Disability Insurance (SSDI) is a payroll
More information